2011Nigerian Veterinary JournalOpen access

Bioequivalence study on two brands of 10% enrofloxacin oral formulations in chickens

FA Gberindyer, NN Wannang, CA Akwuobu

Open full text 0 citations

Abstract

A bioequivalence of two brands of 10% enrofloxacin was tested in broiler chickens using a parallel design at 20 mg/kg bodyweight orally. Blood was sampled before and after drug administration for 24 hours. Plasma enrofloxacin concentrations were analyzed using microbiological assay. Peak plasma concentrations (Cmax), 1.00 ± 0.05 and 0.91 ± 0.02 ìg/ml were obtained in chickens given Reference and Test brands respectively at 1.00±0.01 and 2.00 ± 0.17 hours respectively. Areas under plasma concentration-time curve (AUC0-24) were 3.79 ± 0.07 and 4.90 ± 0.01 ìg/ml for Reference and Test brands respectively. Ratios of Cmax, and AUC0-24(T/R) were 0.91 and 1.29 respectively. These are within the bioequivalence acceptance range. conflox®-vet and kenflox® are therefore bioequivalent and interchangeable.

Open-access reader

About this research paper

What this paper is about

A bioequivalence of two brands of 10% enrofloxacin was tested in broiler chickens using a parallel design at 20 mg/kg bodyweight orally. Blood was sampled before and after drug administration for 24 hours. Plasma enrofloxacin concentrations were analyzed using microbiological assay. Peak plasma concentrations (Cmax), 1.00 ± 0.05 and 0.91 ± 0.02 ìg/ml were obtained in chickens given Reference and Test brands respectively at 1.00±0.01 and 2.00 ± 0.17 hours respectively. Areas under plasma concentration-time curve (AUC0-24) were 3.79 ± 0.07 and 4.90 ± 0.01 ìg/ml for Reference and Test brands respectively. Ratios of Cmax, and AUC0-24(T/R) were 0.91 and 1.29 respectively. These are within the bioequivalence acceptance range. conflox®-vet and kenflox® are therefore bioequivalent and interchangeable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A bioequivalence of two brands of 10% enrofloxacin was tested in broiler chickens using a parallel design at 20 mg/kg bodyweight orally. Blood was sampled before and after drug administration for 24 hours. Plasma enrofloxacin concentrations were analyzed using microbiological assay. Peak plasma concentrations (Cmax), 1.00 ± 0.05 and 0.91 ± 0.02 ìg/ml were obtained in chickens given Reference and Test brands respectively at 1.00±0.01 and 2.00 ± 0.17 hours respectively. Areas under plasma concentration-time curve (AUC0-24) were 3.79 ± 0.07 and 4.90 ± 0.01 ìg/ml for Reference and Test brands respectively. Ratios of Cmax, and AUC0-24(T/R) were 0.91 and 1.29 respectively. These are within the bioequivalence acceptance range. conflox®-vet and kenflox® are therefore bioequivalent and interchangeable.

Key concepts: Bioequivalence, Enrofloxacin, Cmax, Broiler, Pharmacokinetics, Bioavailability, Plasma concentration, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence study on two brands of 10% enrofloxacin oral formulations in chickens — Research Paper | ScholarLens